Minimally Displaced Femoral Neck Fracture Pilot Study
Multicenter Randomized Controlled Trial Comparing Hip Arthroplasty to Internal Fixation for Minimally Displaced Femoral Neck Fractures: A Pilot Study
1 other identifier
interventional
40
3 countries
12
Brief Summary
The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-energy minimally displaced femoral neck fracture (FNF) treated with surgery will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, hip arthroplasty or internal fixation. Participants will be followed for 1 year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Typical duration for not_applicable
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2023
CompletedFirst Posted
Study publicly available on registry
July 17, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 13, 2026
February 1, 2026
3.1 years
June 2, 2023
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility of Participant Enrollment
Participant enrollment will be assessed by monitoring screening and enrollment metrics, including: * Proportion of clinical sites initiated and able to screen consecutive patients with minimally displaced FNF * Proportion of patients who are screened for eligibility to participate in the trial * Proportion of patients who meet the eligibility criteria * Proportion of patients who provide informed consent * Proportion of time required to enroll at least four participants per clinical site * Proportion of reasons for exclusion.
12 months
Feasibility of Treatment Allocation
Feasibility of the treatment allocation will be assessed using the following metrics: * Adherence to arthroplasty treatment allocation * Adherence to internal fixation treatment allocation
12 months
Refine Data Collection Methods
To refine the data collection methods, the following metrics will be reviewed: * Proportion of participants with missing data * Review of missing data to identify data fields that are not feasible to collect * Data errors to identify ways to improve the flow of the case report forms (CRFs) and data collection
12 months
Assess Protocol Compliance
The following metrics will be used to assess compliance with the protocol: * Proportion of randomization errors * Proportion of participants who complete each follow-up visit * Proportion of participants who withdraw from the trial (withdrawal of consent) * Proportion of participants who cannot be located (loss to follow-up)
12 months
Study Arms (2)
Arthroplasty
EXPERIMENTALA modern porous-coated press-fit or cemented hip arthroplasty prosthesis will be used at the treating surgeon's discretion. Press-fit implants that have no ingrowth or ongrowth surface will not be permitted. We recommend surgeons consider a total hip arthroplasty for younger active, independent participants; conversely, a hemiarthroplasty is recommended for more frail, lower-demand participants. Similarly, cemented arthroplasty for older adult participants is also recommended. The surgical approach and the use of post-operative hip precautions will be determined by the treating surgeon.
Internal Fixation
ACTIVE COMPARATORBased on the fracture displacement eligibility criteria, minimal or no reduction is expected during the surgical procedure. However, the treating surgeon will be allowed to perform fracture reduction maneuvers if desired. Fixed angle devices and multiple screws will be permitted. The internal fixation device(s) will be inserted through a small lateral incision. If using multiple cancellous screws, an inverted triangle or similar screw pattern is recommended. Fixed angle devices, such as a sliding hip screw (with or without an anti-rotation screw) or newer multi-screw fixed angle devices will also be permitted. Internal fixation constructs combining cancellous screws and fixed angle devices will be permitted.
Interventions
The type of hip prothesis (hemi or total; cemented or uncemented) will be at the discretion of the treating surgeon.
Both fixed angle devices and multiple screws will be permitted for the internal fixation group.
Eligibility Criteria
You may qualify if:
- Patients 60 years of age or older.
- Complete fracture of the femoral neck (AO/OTA 31B) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI).
- Minimally displaced fracture that could be, in the judgment of the attending surgeon, optimally managed with either arthroplasty or in situ internal fixation without reduction.
- Low energy injury mechanism defined as a fall from standing height.
- Informed consent obtained from patient or proxy.
- Surgeons with expertise in total hip arthroplasty, hemiarthroplasty, and internal fixation are available to perform surgery. Note: Surgeons do not need to be experts in all techniques.
You may not qualify if:
- Unable to ambulate 10 feet pre-injury with any assistance.
- Associated lower extremity injury that prevents post-operative weightbearing.
- Retained hardware around the hip that precludes either study treatment.
- Infection around the hip (soft tissue or bone).
- Pathologic fracture with a lytic lesion in the femoral neck that precludes internal fixation.
- Patient is too ill, in the judgement of the attending surgeon, for internal fixation.
- Patient is too ill, in the judgement of the attending surgeon, for arthroplasty.
- Unable to obtain informed consent due to language barriers.
- Problems, in the judgment of study personnel, with maintaining follow-up with the patient.
- Currently enrolled in a study that does not permit co-enrollment.
- Prior enrollment in the trial.
- Other reason to exclude the patient, as approved by the Methods Centre.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Maryland, Baltimorelead
- McMaster Universitycollaborator
- Orthopaedic Trauma Associationcollaborator
- University of Southern Californiacollaborator
- University of California, Irvinecollaborator
Study Sites (12)
University of Southern California
Los Angeles, California, 90007, United States
Yale University
New Haven, Connecticut, 06520, United States
University of Florida
Gainesville, Florida, 32611, United States
University of Maryland, R Adams Cowley Shock Trauma Center
Baltimore, Maryland, 21201, United States
University of Maryland Capital Region Health
Largo, Maryland, 20774, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
Inova Fairfax Medical Campus
Falls Church, Virginia, 22042, United States
University of British Columbia
Vancouver, British Columbia, V6T 1Z2, Canada
Hamilton Health Sciences
Hamilton, Ontario, L8V 1C3, Canada
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
Vall d'Hebron University Hospital
Barcelona, 08035, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gerard Slobogean, MD
University of Maryland, Baltimore
- PRINCIPAL INVESTIGATOR
Sheila Sprague, PhD
McMaster University
- PRINCIPAL INVESTIGATOR
Joseph Patterson, MD
University of Southern California
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 2, 2023
First Posted
July 17, 2023
Study Start
November 1, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 13, 2026
Record last verified: 2026-02